Home / Japan / BrightPath Biotherapeutics Co.,Ltd.
BrightPath Biotherapeutics Co.,Ltd.
Short position disclosed on August 10, 2026.
1.61% of the capital sold short
1 disclosing funds
9 disclosures on record
Evolution of the disclosed total
0%1%2%3%
Aug 5Aug 7Aug 9Aug 11Aug 13
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| JPM Securities Japan Co Ltd. | 1.61% | new | August 10, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 10, 2026 | JPM Securities Japan Co Ltd. | 1.61% | still open |
| August 7, 2026 | Nomura International plc | 2.57% | still open |
| August 6, 2026 | Nomura International plc | 2.60% | still open |
| August 5, 2026 | Nomura International plc | 2.53% | still open |
| August 5, 2026 | Barclays Capital Securities Ltd | 1.61% | still open |
| August 5, 2026 | Goldman Sachs International | 0.41% | still open |
| August 4, 2026 | Barclays Capital Securities Ltd | 1.76% | still open |
| August 4, 2026 | Goldman Sachs International | 0.66% | still open |
| August 3, 2026 | Barclays Capital Securities Ltd | 1.82% | still open |
Other companies sold short in Japan
- Unitika LTD. 15.46% of the capital sold short
- Sanrio Company,Ltd. 11.32% of the capital sold short
- KLab Inc. 11.02% of the capital sold short
- Kasumigaseki Capital Co.,Ltd. 10.08% of the capital sold short
- AKIBA Holdings Co.,Ltd. 9.88% of the capital sold short
- Fixstars Corporation 9.36% of the capital sold short
- eole Inc. 9.28% of the capital sold short
- QD Laser,Inc. 9.21% of the capital sold short
- Nissan Motor Co.,ltd. 7.80% of the capital sold short
- inspec Inc. 7.79% of the capital sold short
- AIMECHATEC,Ltd. 7.72% of the capital sold short
- Informetis Co.,Ltd. 7.72% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, BrightPath Biotherapeutics Co.,Ltd., source JPX, data as at August 10, 2026, https://www.quivad.com/action/brightpath-biotherapeutics-co-ltd